Table 4.
Blood Tests for Patients in Simvastatin and Placebo Groups for Baseline and 24 Months
| Baseline, Mean ± SD |
24 Mos, Mean ± SD |
P | |||
|---|---|---|---|---|---|
| Simvastatin | Placebo | Simvastatin | Placebo | ||
| RBG, mmol/L | 6.68 ± 3.39 | 5.25 ± 1.09 | 5.29 ± 1.12 | 5.71 ± 2.94 | 0.400 |
| HbA1c, mmol/mmol (%) | 6.21 ± 1.77 | 5;.76 ± 0.33 | 6.16 ± 1.06 | 5.63 ± 0.41 | 0.504 |
| Total cholesterol, mmol/L | 5.29 ± 1.01 | 5.59 ± 1.08 | 4.56 ± 1.48 | 5.42 ± 0.77 | 0.172 |
| LDL, mmol/L | 2.88 ± 0.68 | 3.07 ± 0.75 | 2.14 ± 1.31 | 2.63 ± 0.86 | 0.253 |
| HDL, mmol/L | 1.76 ± 0.62 | 1.89 ± 0.61 | 1.7 ± 0.67 | 1.84 ± 0.64 | 0.713 |
| Triglyceride, mmol/L | 1.42 ± 0.53 | 1.4 ± 0.58 | 1.59 ± 1.01 | 2.15 ± 0.9 | 0.278 |
| Creatinine kinase, umol/L | 128.63 ± 78.88 | 136.38 ± 100.16 | 221.7 ± 198.21 | 130.43 ± 74.0 | 0.246 |
HbA1C = hemoglobin A1C; HDL = high-density lipoprotein; LDL = low-density lipoprotein; RBG = random blood glucose; SD = standard deviation.